ORGANON & CO (NYSE: OGN)

NYSE: OGN (Organon & Co.)

Kemas kini terakhir: 22 jam lalu

-0.19 (-1.87%)

Tambah ke senarai pantauan

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Drug Manufacturers - General (US)	Menurun	Bercampur
	Drug Manufacturers - General (Global)	Menurun	Bercampur
Stok	Organon & Co.	Menurun	Menurun

AISkor Stockmoo

1.5

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
OGN	3 B	8.43%	3.46	4.87
LLY	701 B	0.53%	63.68	44.16
NVO	316 B	2.33%	18.64	14.02
NVS	244 B	3.19%	19.11	6.23
MRK	203 B	2.95%	11.76	4.11
JNJ	375 B	2.38%	17.35	4.81

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women’s health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Sektor	Healthcare
Industri	Drug Manufacturers - General
Gaya Pelaburan	Small Value
% Dimiliki oleh Orang Dalam	0.24%
% Dimiliki oleh Institusi	80.89%

Pemilikan

Nama	Tarikh	Syer Dipegang
Sound Shore Management Inc /Ct/	31 Mar 2025	4,977,078

Syarikat	Tarikh	Harga Sasaran	Panggilan	Harga @ Panggilan
Piper Sandler	15 May 2025	18.00 (80.72%)	Beli	8.77
Morgan Stanley	05 May 2025	10.00 (0.40%)	Pegang	8.72
Morgan Stanley	09 Apr 2025	15.00 (50.60%)	Pegang	12.64

Tiada data dalam julat masa ini.

Tarikh	Jenis	Butiran
02 Jul 2025	Pengumuman	Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
18 Jun 2025	Pengumuman	SHAREHOLDER DEADLINE: Organon & Co. (OGN) Investors Are Reminded of Deadline in Securities Action
12 Jun 2025	Pengumuman	ATTENTION ORGANON & CO. (OGN) SHAREHOLDERS: Securities Fraud Lawsuit Filed Against Organon & Co.
01 May 2025	Pengumuman	Organon Reports Results for the First Quarter Ended March 31, 2025
15 Apr 2025	Pengumuman	Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025
15 Apr 2025	Pengumuman	Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors

Hasil Dividen (DY TTM)	8.43%
Purata Hasil Dividen 4T	5.53%
Nisbah Pembayaran	38.89%
Jangkaan Pembayaran Dividen Seterusnya	Sep 2025

Tarikh EX	Tarikh Pengumuman	Tarikh Pembayaran	Perincian
24 Feb 2025	13 Feb 2025	13 Mar 2025	0.28 Tunai
12 Nov 2024	31 Oct 2024	12 Dec 2024	0.28 Tunai
16 Aug 2024	06 Aug 2024	12 Sep 2024	0.28 Tunai
10 May 2024	02 May 2024	13 Jun 2024	0.28 Tunai
23 Feb 2024	15 Feb 2024	14 Mar 2024	0.28 Tunai
10 Nov 2023	02 Nov 2023	14 Dec 2023	0.28 Tunai
17 Aug 2023	08 Aug 2023	14 Sep 2023	0.28 Tunai
12 May 2023	04 May 2023	15 Jun 2023	0.28 Tunai
24 Feb 2023	16 Feb 2023	16 Mar 2023	0.28 Tunai
11 Nov 2022	03 Nov 2022	15 Dec 2022	0.28 Tunai
10 Nov 2022	03 Nov 2022	15 Dec 2022	0.28 Tunai
12 Aug 2022	04 Aug 2022	15 Sep 2022	0.28 Tunai
13 May 2022	05 May 2022	16 Jun 2022	0.28 Tunai
25 Feb 2022	17 Feb 2022	17 Mar 2022	0.28 Tunai
19 Nov 2021	11 Nov 2021	16 Dec 2021	0.28 Tunai
20 Aug 2021	12 Aug 2021	13 Sep 2021	0.28 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun	Dividen Tahunan ($)	Kekerapan/Tahun	Hasil %
2025	0.280	1	2.81
2024	1.12	4	7.51
2023	1.12	4	7.77
2022	1.40	5	5.01
2021	0.560	2	1.84

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Margin Keuntungan	11.92%
Margin Operasi (TTM)	21.48%
EPS Cair (TTM)	2.88
Pertumbuhan Hasil Suku Tahunan (YOY)	-6.70%
Pertumbuhan Pendapatan Suku Tahunan (YOY)	-56.70%

Jumlah Hutang/Ekuiti (D/E MRQ)	1,652.40%
Nisbah Semasa (MRQ)	1.67
Aliran Tunai Operasi (OCF TTM)	938.00 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	456.75 M

Pulangan Atas Aset (ROA TTM)	6.98%
Pulangan Atas Ekuiti (ROE TTM)	254.24%